Bunkerhill Abdominal Aortic Quantification (AAQ) vs Tempus ECG-AF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Bunkerhill Abdominal Aortic Quantification (AAQ)
by Bunkerhill Health
VS
Tempus ECG-AF
by Tempus AI, Inc.

AI Verdict

Tool A focuses on automating the quantification of abdominal aortic diameter from CT scans for aneurysm detection and follow-up. In contrast, Tool B analyzes 12-lead ECGs to identify patients at increased risk of developing atrial fibrillation within the next 12 months. While both are cardiology AI tools, they address distinct cardiovascular conditions using different diagnostic modalities.

Choose Bunkerhill Abdominal Aortic Quantification (AAQ) if…

Choose Bunkerhill Abdominal Aortic Quantification (AAQ) if your primary objective is to automate the precise measurement of abdominal aortic diameters from both contrast and non-contrast CT scans. This tool is ideal for radiology and vascular surgery departments looking to implement opportunistic screening for silent aneurysms and streamline guideline-based surveillance and follow-up workflows within a unified platform.

View Bunkerhill Abdominal Aortic Quantification (AAQ) →

Choose Tempus ECG-AF if…

Choose Tempus ECG-AF if your focus is on identifying patients aged 65 or older at an elevated risk of developing new-onset atrial fibrillation within the next 12 months, utilizing existing 12-lead ECG recordings. This solution is particularly valuable for cardiology, geriatrics, and internal medicine practices aiming for earlier detection and proactive management of AF risk in eligible patient populations.

View Tempus ECG-AF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Bunkerhill Abdominal Aortic Quantification (AAQ) Tempus ECG-AF
Pricing Unknown Contact vendor
Deployment Cloud-based (Carebricks platform) Software solution, integrated into healthcare facility systems with advanced cardiology algorithms.
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Bunkerhill Abdominal Aortic Quantification (AAQ)

Tool A emphasizes 'seamless integration with Electronic Health Records (EHRs)' and 'automation of appropriate next steps and actions within clinical workflows' through its Carebricks platform. This suggests a more deeply embedded and proactive user experience, streamlining clinical processes directly within existing systems. Tool B focuses on integration into healthcare facility systems and compatibility with specific ECG machines, which is valuable but less indicative of comprehensive workflow automation.

Clinical Value

Bunkerhill Abdominal Aortic Quantification (AAQ)

Both tools are FDA-cleared and address significant clinical needs. Tool A offers 'opportunistic screening for silent aneurysms from routine CTs' and 'guideline-based surveillance and evaluation coordination,' which can detect a life-threatening condition that might otherwise be missed. While Tool B provides early identification of AF risk, Tool A's ability to proactively identify a silent, critical condition from existing imaging provides a unique and substantial clinical impact.

Pricing & Value

Tempus ECG-AF

Tool B explicitly outlines CMS reimbursement availability with specific CPT codes and a Medicare rate, providing clear financial transparency and a direct path to value for healthcare providers. Tool A's pricing is described as 'custom pricing based on deployment and features' with a 'contact for pricing' model, which offers less immediate clarity on its financial value proposition for potential customers.

Enterprise Readiness

Bunkerhill Abdominal Aortic Quantification (AAQ)

Both tools are FDA-cleared, HIPAA compliant, and have BAAs, indicating foundational enterprise readiness. However, Tool A explicitly states it is 'Cloud-based (utilizes AWS for cloud infrastructure)' and offers 'seamless integration with Electronic Health Records (EHRs)'. These details highlight a robust, scalable, and easily deployable architecture well-suited for large healthcare enterprises.

Innovation

Bunkerhill Abdominal Aortic Quantification (AAQ)

Tool A is described as the 'first FDA-cleared AI to automate abdominal aortic diameter quantification' and its tagline emphasizes a 'generative AI platform for clinical reasoning and action.' Its features include 'AI-powered reasoning across structured and unstructured patient data' and 'automation of appropriate next steps,' suggesting a more advanced and comprehensive application of AI beyond pattern recognition. Tool B's AI-based ECG analysis is valuable but represents a more established application of AI in cardiology.

Support & Docs

Tempus ECG-AF

Tempus (Tool B) provides explicit details on its support structure, including phone, email, and live chat channels, along with specified hours of operation and typical response times for urgent requests. Bunkerhill Health (Tool A) provides a general contact email but lacks specific information regarding dedicated support channels, hours, or expected response times.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Bunkerhill Abdominal Aortic Quantification (AAQ) Tempus ECG-AF
Product Name Bunkerhill Abdominal Aortic Quantification (AAQ) Tempus ECG-AF
Company BunkerHill Health Tempus AI, Inc.
Core Functionality Automates abdominal aortic diameter quantification on contrast and non-contrast CT scans for early aneurysm detection and streamlined follow-up; includes opportunistic screening, guideline-based surveillance, detection of interval growth, and AI-powered reasoning for workflow automation. AI-based algorithm analyzing 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months.
Target Data/Patient Population Abdominal CT scans (contrast and non-contrast) for aneurysm detection. 12-lead ECG recordings for patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery.
Specialties Cardiology, Radiology, Vascular Surgery Cardiology, Geriatrics, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill Abdominal Aortic Quantification (AAQ) and Tempus ECG-AF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Bunkerhill AAQ automates abdominal aortic diameter quantification on CT scans, enabling opportunistic screening for aneurysms and streamlining follow-up within the Carebricks platform, leading to automated next steps and guideline-based surveillance. Tempus ECG-AF analyzes 12-lead ECGs to identify patients 65 or older at increased risk of developing new-onset atrial fibrillation within 12 months, supporting earlier identification and follow-up to potentially improve patient outcomes.
Bunkerhill AAQ offers seamless integration with Electronic Health Records (EHRs) to incorporate AI-powered reasoning across structured and unstructured patient data and automate appropriate next steps within clinical workflows. Tempus ECG-AF is designed to work with existing ECG platforms and EHRs, integrating into healthcare facility systems with advanced cardiology algorithms to enable advanced AI deployment and insights within clinical workflows.
Bunkerhill AAQ focuses on automating abdominal aortic diameter quantification on contrast and non-contrast CT scans for early aneurysm detection and monitoring interval growth, suitable for general radiology and vascular screening. Tempus ECG-AF targets patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery, using an algorithm trained on over 1.5 million ECGs from over 500,000 patients to predict new-onset AF risk within 12 months.
Bunkerhill AAQ is primarily beneficial for Cardiology, Radiology, and Vascular Surgery, supporting opportunistic screening and ongoing surveillance for abdominal aortic aneurysms. Tempus ECG-AF is designed for Cardiology, Geriatrics, and Internal Medicine, aiding in the early identification of atrial fibrillation risk in an elderly population.
Bunkerhill AAQ streamlines follow-up workflows, automates next steps, and provides guideline-based surveillance, which can accelerate the detection and management of aortic aneurysms by reducing manual work and improving patient safety. Tempus ECG-AF supports earlier identification of patients at risk for AF, potentially leading to more timely interventions and follow-up, thereby improving patient management efficiency.
Bunkerhill AAQ's integration with the Carebricks platform allows for automated follow-up workflows, guideline checks, and longitudinal tracking of aortic measurements, suggesting inherent audit-trail capabilities for changes and protocol adherence. The provided information for Tempus ECG-AF does not explicitly detail audit-trail features for its AI-generated risk assessments, though it supports patient filtering and follow-up consistent with clinical care guidelines.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Bunkerhill Abdominal Aortic Quantification (AAQ) or Tempus ECG-AF

Backers

Who funded each tool's parent company.

Tempus ECG-AF

AI Tool Finder
AI-powered search. Results may not be comprehensive.